Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration-Reference-Cited by-同舟云学术

Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration

Published:2021-04-01 Issue:4 Volume:181 Page:559
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Puthumana Jeremy¹,Egilman Alexander C.²,Zhang Audrey D.³,Schwartz Jason L.⁴,Ross Joseph S.¹²⁴

Affiliation:

1. Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut

2. Center for Outcomes Research and Evaluation, Yale–New Haven Hospital, New Haven, Connecticut

3. Department of Medicine, Duke University School of Medicine, Durham, North Carolina

4. Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2772943/jamainternal_puthumana_2020_ld_200085_1617393600.14581.pdf

Reference4 articles.

1. Regulatory decision-making on COVID-19 vaccines during a public health emergency.;Avorn;JAMA,2020

2. Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012.;Downing;JAMA,2014

3. Associated Press-NORC Center for Public Affairs. Expectations for a COVID-19 vaccine. Accessed August 1, 2020. https://apnorc.org/projects/expectations-for-a-covid-19-vaccine/

4. US Food and Drug Administration. Biological approvals by year. Accessed August 20, 2020. https://www.fda.gov/vaccines-blood-biologics/development-approval-process-cber/biological-approvals-year

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anaphylactic Reactions to COVID-19 Vaccines: An Updated Assessment Based on Pharmacovigilance Data;Vaccines;2023-03-08

2. Anaphylaxis rates following mRNA COVID-19 vaccination in children and adolescents: Analysis of data reported to EudraVigilance;Vaccine;2023-03

3. ASSIGNED AND DOSE-APPLIED VACCINES AGAINST COVID-19 IN COLOMBIA: A SIGNIFICANT ADVANCE;CULT CIENT;2023

4. Vacunas, certificados COVID y control de fronteras: reflexiones en torno al caso Djokovic;Revista Chilena de Derecho;2022-12-06

5. Neutralizing antibody responses in healthcare personnel after three doses of mRNA BNT162b2 vaccine and association with baseline characteristics and past SARS-CoV-2 infection;Vaccine;2022-09